Workflow
Pharmaceuticals
icon
Search documents
Stocks & Bonds Rose as US-Iran Hopes Spur Oil Drop | The Close 8/3/2026
Bloomberg Television· 2026-08-03 22:33
Market Trends & Macroeconomic Environment - S&P 500 closed above all key moving averages after a turbulent July with back-to-back gains[1], while the Nasdaq 100 and Nasdaq Composite each rose about 2%[119] - Oil prices dropped 5% on a weekly basis and 5% on a daily basis, having a significant downward impact on energy costs[2] - U.S.-led currency intervention to contain the drop in the yen kept Japan from selling U.S. Treasuries, contributing to a bond market rally and lower yields[3] - U.S. factory activity surged to the highest level since 2022, with manufacturers increasing headcount for the first time since 2023[5][6] - The Federal Reserve held the federal funds rate at 3.5% to 3.75%, while forward-looking inflation metrics remained anchored[17][20] - The default rate across 1,300 U.S. private debt borrowers rose to a high of 6%, though rating methodology differences across agencies contributed to varying default rate calculations[51][54] Corporate Earnings & Financial Performance - S&P 500 Q2 earnings growth reached 35% to 40%, largely driven by technology, while valuations dropped back down to some of the lowest levels seen since 2020[8][10] - Palantir reported strong Q2 results, raising its full-year revenue guidance from a range of $7.66 billion to a tight range of $8.15 billion to $8.16 billion[111] - On Semiconductor reported adjusted EPS of $0.74 and quarterly revenue of $1.6 billion, beating analyst estimates[115] - Amazon crossed a $3 trillion market cap for the first time, becoming the fifth company ever to reach this milestone, while Boeing shares rose 8% following FAA certification for the 737 Max 7[103][104][105] Industry Developments & Potential Risks - The White House outlined $200 billion in spending per year to support individual scientists and private research facilities, with up to $5 billion allocated toward AI research and streamlined FDA review processes[23][31][32] - Bristol-Myers Squibb and AstraZeneca held early-stage talks regarding a potential megamerger that could become the largest pharma deal in history, though AstraZeneca shares fell as much as 10% amid investor pushback[39][40] - Yum Brands faced pressure and a 3% share decline following a parasitic Cyclospora outbreak tied to iceberg lettuce in Michigan that prompted early health authority investigations[49][109] - Yellow Card raised a $40 million funding round backed by strategic investors including SC Ventures and Sony Innovation Fund to expand its global stablecoin infrastructure and cross-border payment accounts[159][160][162]
"Bull Market Could Last Through 2030:" Bartels | Open Interest 8/3/2026
Bloomberg Television· 2026-08-03 17:41
Pharmaceuticals and Healthcare M&A - AstraZeneca experienced a 7% stock decline following early-stage merger talks with Bristol-Myers Squibb [1][2][48] - Bristol-Myers Squibb shares increased by 2.7%, with the potential combination projected to create the world's largest drug maker generating approximately $107 billion in annual revenue [2][48] - KKR agreed to acquire Integer in an all-cash deal valued at more than $5 billion [27][86] Commodities and Precious Metals - Brent crude dropped by 5% and 5.6% as geopolitical tensions eased regarding potential conflict with Iran [24][47][118] - Standard Chartered established a gold price target of $4,200, projecting a Q3 average of $4,300 and reaching $4,650 in Q4 [188][194] Financial Markets and Asset Management - Jefferies faced exposure issues through its Point Bonita fund, with peak exposure reaching $500 million and dropping to less than $300 million [32][33] - KKR raised a record $19.2 billion for its largest-ever infrastructure mega-fund [86][88] - Major tech companies achieved massive market capitalizations, with Amazon crossing the $3-trillion market cap threshold [57][68]
Squawk Pod: Kalshi CEO on NY’s lawsuit, a Yen-tervention, water cyberattacks- 08/03/26 | Audio Only
CNBC Television· 2026-08-03 17:11
Regulatory & Legal Dynamics - New York State sued prediction market platform Kalshi, alleging the platform constitutes illegal gambling and seeking restitution and penalties totaling approximately 36 billion dollars [1][4][51] - The Commodity Futures Trading Commission (CFTC) intervened in legal disputes, arguing that prediction market regulation falls under federal jurisdiction rather than state authority [50] - Kalshi proposed a taxation structure that could generate close to 10 billion dollars over 5 years from the prediction market industry [20] Market Performance & Business Growth - Sony and Marvel's new Spider-Man film earned an estimated 355 million dollars in domestic box office and 570 million dollars internationally, bringing its total opening weekend to 927 million dollars [3] - British pharmaceutical company AstraZeneca engaged in merger talks with US-based Bristol Myers Squibb to create a pharmaceutical giant valued at approximately 400 billion dollars [3] - Bristol Myers Squibb holds a market capitalization of 133 billion dollars [3] Cybersecurity & Infrastructure Threats - Municipal water systems in at least seven states, including Minnesota with 30 affected systems and Michigan with 9, became targets of cyber attacks suspected to originate from Iran [64][67] - Government agencies reported that threat actors stole industrial computer project files and shut down alarm logic to cause operational disruptions [69][70] - Approximately 5,000 industrial computers from manufacturers remained internet-exposed due to inadequate isolation practices [72]
X @Bloomberg
Bloomberg· 2026-08-03 16:30
Closely held nuclear medicine company Curium has struck a deal to take Lantheus Holdings private in a transaction worth about $8 billion https://t.co/kREpn6VqrU ...
Astra Buying Bristol Makes No Sense, Fazeli Says
Bloomberg Television· 2026-08-03 15:38
Big deal in the pharma space. AstraZeneca down 7%, Bristol-Myers up 2.7%. After the companies reportedly held early stage talks for a potential merger.That combination would create the world's biggest drug maker with about $107 billion in annual revenue. Let's bring in Bloomberg Intelligence senior pharmaceutical analyst Sam Ali for more on this. Sam, what would be the reasoning. What would be the logic behind forming such a behemoth of a drug company.Um, none. Zero. There's really no, uh, I mean, every cli ...
AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed'
CNBC Television· 2026-08-03 15:20
So this deal would put this as one of the biggest pharma deals in history. These companies are, you know, worth more than $130 billion each. And so the joint company would be a $400 billion company here.That puts it behind Eli Liy, Johnson and Johnson, and Abby as the biggest pharma companies out there. And so, you know, when you think about the strategy behind this deal, it isn't really a surprise for Astroenica. You know, the company has been working to expand its presence in the US market.Just last month ...
X @Bloomberg
Bloomberg· 2026-08-03 15:10
A mooted $400 billion tie-up between AstraZeneca and Bristol-Myers Squibb could get really messy, writes @hughes_chris (via @opinion) https://t.co/ulzCPdGgej ...
Market Open: Stocks Up, Iran Talks Resume, US Props Up Yen • 8/3/26
CNBC Television· 2026-08-03 14:24
Market Trends and Macroeconomic Indicators - Wall Street indices opened higher on the first day of August trading, with the Dow Jones Industrial Average rising 648 points or 1.25%, the S&P 500 index increasing by 45 points or 0.5%, and the Nasdaq gaining 133 points or 0.5% [1] - The Nasdaq concluded July coming off its worst performing month since March 2025, though major market averages remained higher for the year [2] - Crude oil prices fell by more than 6%, with US crude dropping below $80 per barrel amid optimism surrounding US-Iran talks and potential war de-escalation [1][2] - The national average price for a regular gallon of gasoline held steady at approximately $4.09, while inflation metrics showed shelter costs decreasing rapidly in regions like California due to population outflow [3][4] - The average interest rate on a 30-year fixed home loan hovered at 6.83%, approaching the 7% threshold and marking some of the highest mortgage rates seen in a year [4] - The United States government intervened to support the Japanese yen in the first currency intervention in 15 years, as the yen weakened to its lowest level against the dollar in nearly 40 years [5] Industry Dynamics and Corporate Performance - Technology giants experienced share price growth, with Microsoft and Amazon shares both soaring by more than 4% in morning trading [1] - Pharmaceutical companies AstraZeneca and Bristol Myers weighed a potential mega-merger valued at roughly $400 billion, which would rank among the largest pharma deals in history [6] - Canadian airline WestJet, the country's second-largest airline, reached a tentative pay deal allowing flight attendants to end a strike that had prompted the cancellation of hundreds of flights during a three-day holiday weekend [7][8] - Marriott International shares declined in early trading following mixed quarterly results, despite the company raising its outlook for room revenue growth [8] - Sony's Spider-Man movie generated an estimated $355 million during its opening weekend, drawing over 24 million viewers in the United States and Canada to mark the second-biggest domestic opening weekend record in history [9]
X @Bloomberg
Bloomberg· 2026-08-03 13:50
Market Dynamics - AstraZeneca investors opposed the potential merger proposal valued at $400 billion (四千亿美元) with Bristol-Myers Squibb Co [1] Industry Trends - Pharmaceutical sector stakeholders showed negative sentiment toward large-scale cross-company consolidation moves [1]
X @Forbes
Forbes· 2026-08-03 13:31
Market Trends - Forbes Daily covered America's Top HBCUs and the impact of New York City's pied-à-terre tax [1] - The cryptocurrency market experienced a significant bitcoin plunge [1] Industry Dynamics - Healthcare sector monitored stock performance fluctuations for Novo Nordisk [1]